BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,615,368 | -24.5% | 148,790 | -8.9% | 0.01% | -25.0% |
| Q2 2023 | $7,441,769 | +8.5% | 163,340 | -3.4% | 0.01% | 0.0% |
| Q1 2023 | $6,856,790 | -26.0% | 169,053 | -7.0% | 0.01% | -25.0% |
| Q4 2022 | $9,261,402 | +7.9% | 181,703 | +14.0% | 0.02% | -11.1% |
| Q3 2022 | $8,582,000 | -28.2% | 159,335 | -14.3% | 0.02% | -21.7% |
| Q2 2022 | $11,946,000 | -20.2% | 185,983 | -3.7% | 0.02% | -8.0% |
| Q1 2022 | $14,977,000 | -11.9% | 193,146 | -2.5% | 0.02% | -7.4% |
| Q4 2021 | $17,005,000 | +4.4% | 198,092 | -2.1% | 0.03% | -12.9% |
| Q3 2021 | $16,281,000 | -2.7% | 202,442 | -2.6% | 0.03% | 0.0% |
| Q2 2021 | $16,739,000 | -12.6% | 207,931 | -8.4% | 0.03% | -20.5% |
| Q1 2021 | $19,147,000 | -2.5% | 227,027 | -7.2% | 0.04% | -7.1% |
| Q4 2020 | $19,632,000 | -3.7% | 244,658 | -3.5% | 0.04% | -16.0% |
| Q3 2020 | $20,385,000 | -8.4% | 253,473 | -1.9% | 0.05% | -13.8% |
| Q2 2020 | $22,257,000 | +3.9% | 258,499 | -2.0% | 0.06% | -13.4% |
| Q1 2020 | $21,417,000 | -7.6% | 263,785 | -4.9% | 0.07% | +13.6% |
| Q4 2019 | $23,189,000 | -21.0% | 277,304 | -17.4% | 0.06% | -26.2% |
| Q3 2019 | $29,349,000 | +5.4% | 335,535 | -1.3% | 0.08% | +2.6% |
| Q2 2019 | $27,854,000 | -1.0% | 340,092 | -1.7% | 0.08% | -3.7% |
| Q1 2019 | $28,126,000 | +22.2% | 345,895 | -1.1% | 0.08% | +9.5% |
| Q4 2018 | $23,021,000 | -23.4% | 349,759 | -10.3% | 0.07% | -14.9% |
| Q3 2018 | $30,064,000 | +4.2% | 389,988 | -0.2% | 0.09% | -1.1% |
| Q2 2018 | $28,857,000 | +13.8% | 390,812 | +0.3% | 0.09% | +12.8% |
| Q1 2018 | $25,354,000 | +0.1% | 389,833 | -0.5% | 0.08% | +1.3% |
| Q4 2017 | $25,317,000 | +4.2% | 391,660 | +1.2% | 0.08% | -1.3% |
| Q3 2017 | $24,291,000 | +1.3% | 387,085 | -2.2% | 0.08% | -2.5% |
| Q2 2017 | $23,973,000 | +13.1% | 395,982 | -3.1% | 0.08% | +9.6% |
| Q1 2017 | $21,198,000 | +17.9% | 408,750 | +0.8% | 0.07% | +12.3% |
| Q4 2016 | $17,986,000 | -9.7% | 405,648 | -3.0% | 0.06% | -12.2% |
| Q3 2016 | $19,916,000 | +2.5% | 418,406 | -2.6% | 0.07% | 0.0% |
| Q2 2016 | $19,430,000 | +11.8% | 429,671 | +1.6% | 0.07% | +8.8% |
| Q1 2016 | $17,380,000 | +25.9% | 423,065 | +17.0% | 0.07% | +21.4% |
| Q4 2015 | $13,800,000 | +28.9% | 361,726 | +11.0% | 0.06% | +24.4% |
| Q3 2015 | $10,706,000 | -55.9% | 325,907 | -6.2% | 0.04% | -52.1% |
| Q2 2015 | $24,299,000 | -4.0% | 347,472 | -6.0% | 0.09% | -3.1% |
| Q1 2015 | $25,320,000 | -10.8% | 369,633 | -4.6% | 0.10% | -11.8% |
| Q4 2014 | $28,396,000 | +3.7% | 387,449 | +1.5% | 0.11% | -0.9% |
| Q3 2014 | $27,383,000 | -2.2% | 381,536 | -1.5% | 0.11% | -0.9% |
| Q2 2014 | $28,001,000 | +1.2% | 387,303 | +3.0% | 0.11% | -0.9% |
| Q1 2014 | $27,657,000 | +7.1% | 375,882 | +1.2% | 0.11% | +7.6% |
| Q4 2013 | $25,826,000 | +10.9% | 371,335 | +4.8% | 0.10% | +1.9% |
| Q3 2013 | $23,278,000 | -8.7% | 354,371 | -3.8% | 0.10% | -11.2% |
| Q2 2013 | $25,508,000 | – | 368,236 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |